MetaStat, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes MetaSite Breast and MenaCalc platforms. The MetaSite Breast test measures the process of systemic metastasis and is intended for early stage breast cancer patients. The MenaCalc, a platform of diagnostic assays, based on the measurement of the balance of the Mena protein isoforms, is broadly applicable in solid epithelial-based cancers, including breast, prostate, lung and colorectal. The company was founded by Warren C. Lau in July 2009 and is headquartered in Boston, MA.
Company profile
Ticker
MTST
Exchange
Website
CEO
Douglas A. Hamilton
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Photovoltaic Solar Cells, Inc.
SEC CIK
Corporate docs
IRS number
208753132
Latest filings (excl ownership)
15-12G
Securities registration termination
16 Jul 18
8-K
MetaStat Voluntarily Withdraws Listing on the OTCQB and Files Form 15 to Suspend its Reporting Obligations
16 Jul 18
10-K
2018 FY
Annual report
29 May 18
EFFECT
Notice of effectiveness
29 May 18
EFFECT
Notice of effectiveness
29 May 18
POS AM
Prospectus update (post-effective amendment)
25 May 18
POS AM
Prospectus update (post-effective amendment)
25 May 18
D
$3.63M in debt / options / securities to be acquired, sold $3.38M, 6 investors
11 Apr 18
8-K
Entry into a Material Definitive Agreement
5 Apr 18
10-Q
2018 Q3
Quarterly report
16 Jan 18
Latest ownership filings
Institutional ownership, Q3 2019
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|